![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
CLL Clinical Trials for Molecularly Defined Patient Subgroups (Patient Empowerment Network) View |
![]() |
Outcomes from the RESONATE 2 and HELIOS Trials—Clinical Impact (AJMCtv MJH) View |
![]() |
Will knowledge of the molecular pathology of lymphoma improve clinical trials (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
Debate: How should patients with ABC type DLBCL be treated today - R-CHOP (HMP Education) View |
![]() |
Treatment options for the young CLL patient with deletion 17p: Do they need a different approach (HMP Education) View |
![]() |
Molecular classification, biology-based clinical trials and liquid biopsy in lymphoma (VJHemOnc – Video Journal of Hematology \u0026 HemOnc) View |
![]() |
CLL: Update on Approved TKIs (HMP Education) View |
![]() |
Debate: Optimal approach for the management of CLL patients with del(17p) - Novel Agents (HMP Education) View |
![]() |
AML Treatment Challenges Who, When, and How (HMP Education) View |
![]() |
prof peter hillmen Leeds part2 (CLL Support Association (CLLSA)) View |